The evolution of biotechnology and the resulting cost savings have made sequencing genetic analysis (exome, genome, and transcriptome) easily accessible.
The availability of these experimental data is an important opportunity for physicians and patients. However, this opportunity is often not used to its full potential.
The reason is that the interpretation of sequencing data requires advanced knowledge in medical genetics, bioinformatics, and artificial intelligence. These skills are not easily accessible to medical staff. The result is that much of the information in genetic analysis remains unused.
Our goal is to provide patients and medical staff with an analysis service of sequencing experiments based on the latest data analysis techniques.